Costs & timelines
From Product Brief to Finished Cosmetic Sample: The Steps That Actually Matter
Every skincare or beauty line made in Thailand starts the same way: a brand owner has an idea, and a factory needs that idea translated into something it can actually produce. The

Every skincare or beauty line made in Thailand starts the same way: a brand owner has an idea, and a factory needs that idea translated into something it can actually produce. The gap between those two points — the brief and the first finished sample — is where most delays, misunderstandings and budget surprises happen. Understanding the real sequence of steps, and what decisions you're expected to make at each one, puts you in a much stronger position when talking to an OEM manufacturer in Thailand. This guide walks through that process in order, without promising specific timelines or costs that vary case by case.
Step 1: Writing a brief the factory can actually use
A product brief is not a mood board. For a formulation team, a usable brief answers concrete questions: What is the product category (serum, cream, shampoo, sunscreen, supplement)? What texture, scent profile and finish are you aiming for? Who is the end user, and in which market will it be sold? Are there ingredients you want included or excluded, for marketing or regulatory reasons? If you're building out a skincare OEM line or a body care OEM range, it helps to bring reference products — either competitor items you admire or textures you dislike — since describing sensory qualities in words alone is often imprecise. The more specific the brief, the fewer formulation rounds you'll need later.
Step 2: Feasibility review and formulation direction
Once the factory has your brief, the R&D or formulation team checks it against what's realistic: available raw materials, stability requirements, and whether your concept fits an existing base formula or needs to be built from scratch. This is also when category-specific constraints surface — sunscreen OEM projects, for instance, involve UV filter selection and SPF testing considerations that don't apply to a basic lotion. Supplement briefs go through a parallel check on active ingredient dosing and capsule or tablet format. At this stage the manufacturer will usually tell you whether your idea is a straightforward adaptation of a stock formula or a custom development — the two paths differ a lot in complexity.

Step 3: Choosing between a stock base and a custom formula
This is one of the first real trade-off decisions you'll face. Working from an existing base formula is faster to sample and lower-risk, because the texture and stability are already proven — you're mainly adjusting actives, fragrance or color. A fully custom formula gives you more differentiation but requires more rounds of adjustment before it's finished. Neither choice is inherently better; it depends on whether your brand's value proposition rests on a unique formulation or on positioning, packaging and marketing. Brands building hair care ranges often start with a base and customize actives, while fragrance-led products may need more bespoke scent development from the outset.
Step 4: First sample production and evaluation
Once a formulation direction is approved, the factory produces an initial sample batch — small enough to evaluate, not yet at production scale. This is where you assess texture, scent, color, absorption or rinse-off feel, and overall alignment with the original brief. It's useful to test the sample in the actual conditions it will be used in, not just in a lab setting: a body lotion feels different applied after a shower than dabbed on the back of a hand. If packaging compatibility matters — for example how a product behaves in cosmetic bottles and pumps versus jars — this is a good point to start thinking about it, even if packaging selection comes slightly later in the process.

Step 5: Revision rounds and sign-off
Few first samples are approved as-is. Expect at least one or two rounds of adjustment — tweaking fragrance concentration, thickening agents, pH, or active ingredient levels. Each round should be evaluated against the original brief rather than against the previous sample alone, so the product doesn't drift from its intended positioning. This is also the stage to confirm any claims you intend to make on packaging, since formulation needs to support those claims. Once you and the manufacturer agree the sample matches the brief, it's signed off as the reference standard for production — the benchmark every future batch is measured against.
Step 6: What happens after sample approval
Sample approval isn't the end of the development phase — it's the point where packaging, labeling, and regulatory documentation start running in parallel with pre-production planning. For products sold in Thailand or exported, this is when Thai FDA notification and any required testing are addressed; for other export markets, it's worth checking with your own country's import or customs authority on what documentation will be needed on arrival. Pricing and minimum order quantity are also finalized around this stage — contract manufacturing in Thailand typically runs on a standard MOQ of 1,000 units per SKU, though exact costs depend on the formula, packaging and volume, and are confirmed when the manufacturer issues a quote.
Need expert support?
Leave your details and our team will get back to you.
FAQ
Frequently asked questions
How many sample rounds should I expect before approval?
It varies by product complexity and how closely the first sample matches your brief. Simple adaptations of a stock formula may need fewer rounds than a fully custom formulation; the manufacturer can give you a clearer picture once they see your brief and reference products.
Can I request changes after the sample is approved?
Minor adjustments are sometimes possible, but significant changes after sign-off usually mean restarting part of the formulation review, since the approved sample becomes the production reference standard.
Do I need to decide on packaging before the sample stage?
Not necessarily, but it helps to think about it early, especially if you're considering specific cosmetic bottles and pumps, since some packaging types affect formula viscosity or preservation needs.
Is the process different for supplements versus skincare?
The overall sequence — brief, feasibility, formulation, sample, revision, sign-off — is similar, but supplement manufacturing involves additional checks on active dosing and capsule or tablet format that skincare formulations don't require.
Prepared by the OEM Thailand team for informational purposes. Some links may lead to referred partners.
Articles
Related articles

How MOQ Works in Cosmetic Manufacturing: A Brand Owner's Guide
Understanding how MOQ works in cosmetic manufacturing changes the conversation with a factory from haggling into problem solving. A minimum
What Drives OEM Skincare Cost? A Plain-English Breakdown
Ask three factories for a quote on the same skincare idea and you'll likely get three very different numbers. That's not because someone is overcharging — it's because "cost" in co

How Long Cosmetic OEM Takes From Brief to Launch: A Realistic Timeline
Brand owners planning a launch almost always ask the same question first: how long cosmetic OEM takes from brief to launch. The honest answer is that there's no single number that

How to Calculate the Total Cost of Launching a Skincare Line
Most first-time brand owners price their skincare launch using a single number: the per-unit manufacturing quote. That's a mistake. The real total cost of launching a skincare line

Cosmetic Manufacturing Timeline Explained: What Really Happens Between Idea and Launch
Brand owners asking about a cosmetic manufacturing timeline usually want one number — "how many weeks?" The honest answer is that there is no single number, because the timeline is

What Causes Delays in a Cosmetic Manufacturing Schedule? 7 Culprits
Most launch dates slip for reasons that were visible weeks earlier. Understanding what causes delays in cosmetic manufacturing schedule planning lets a brand owner spot the warning